Chiesi Group, a research-oriented international biopharmaceutical group, has launched The Impulse, an innovation platform designed to accelerate bold ideas and meaningful partnerships in healthcare.
The platform aims to tackle some of the biggest challenges facing patients, the planet, and people today by addressing not only symptoms but also the root causes of these challenges, such as climate change and access to care.
Empowering Innovation through Collaboration
Chiesi continuously invests in research and development to create new healthcare solutions for patients globally.
The Impulse was launched at Frontiers Health in Berlin and will provide resources, mentorship, and a global network for innovators, researchers, and startups to bring forward-thinking healthcare solutions to life.
The platform has already begun to attract interest from key players in the life sciences, digital health, and environmental sustainability sectors, including the Karolinska Institutet, NOME, and EIT-HEALTH, with more partnerships in the pipeline.
Related: Chiesi Pledges Commitment to Planet and Patients
A Commitment to Patients and the Planet
As the healthcare industry faces growing pressure to rethink traditional care models, with climate change and sustainability central to global health discussions, Chiesi is offering more environmentally friendly solutions.
The Impulse creates a collaborative space for researchers, start-ups, and innovators to work together to drive solutions that not only improve patient outcomes but also contribute to a healthier planet for future generations.
Sustainability is deeply rooted in Chiesi‘s strategy and vision, and the company has adopted the Benefit Corporation legal status in Italy, the US, and France, and it constantly monitors its ESG performances through the B Corp certification measurement framework.
Chiesi is committed to empowering the next generation of digital health solutions, from wearable technology to AI-driven diagnostics and telemedicine systems that connect patients with providers globally.
Forward-thinking Healthcare Solutions
The Impulse is designed to meet the growing need for pharma and healthcare solutions that meet the real needs of patients, and it is technology agnostic.
The platform not only aims to improve patient outcomes but also addresses wider societal challenges, underlining Chiesi‘s ongoing commitment to innovation and sustainability.
Related: EU respiratory health plan takes shape
In practice, this development means that patients and healthcare providers will have access to more innovative and sustainable solutions, which can lead to better health outcomes and a reduced environmental impact.
For example, The Impulse can facilitate the development of new treatments and therapies that are not only effective but also environmentally friendly, which can have a positive impact on the health of both people and the planet.
As Fabrizio Conicella, Vice-President Center of Open Innovation & Competence, said, “We stand at a key moment for the pharmaceutical industry. This is the time to further rethink traditional models and adopt bolder, patient-centric innovation. That’s why Chiesi has created The Impulse, aiming to empower those who are driven by a passion to improve the lives of others through innovation,”
Chiesi has created The Impulse to empower those who are driven by a passion to improve the lives of others through innovation, and the platform is expected to have a tangible impact on patients and the world around us.
For more information on The Impulse and how to get involved, visit Chiesi’s website.
Leave a Reply